• SENSEX 74,294.96
    -19.63 (--0.03%)
  • BANKNIFTY 56,358.70
    302.95 (+0.54%)
  • HDFC Bank
    733.50 1,020.35(%)
  • ITC
    262.20 256.25(%)
  • The Bombay Burmah
    1,531.60 2,135.00(%)
  • Rentomojo
    492.20 480.00(%)
  • Glass Wall Syst.
    304.50 304.50(%)
  • Multi Comm. Exc.
    3,232.00 1,545.65(%)
  • UltraTech Cem.
    10,670.00 10,329.00(%)
  • Adani Total Gas
    674.80 859.70(%)
  • EIH
    320.50 414.90(%)
  • Bajaj Finance
    1,036.10 1,177.60(%)
  • Lords Mark Industries
    89.68 669.70(%)
  • Meesho
    219.80 254.65(%)
  • Syrma SGS Tech.
    1,764.95 1,764.95(%)
  • Aditya Birla Cap
    404.25 430.55(%)
  • Raksan Transformers
    286.65 286.65(%)
  • Atul
    6,195.10 7,198.20(%)
  • Karamtara Engg.
    378.20 378.20(%)
  • TCS
    2,101.00 1,976.00(%)
  • Billionbrains
    195.50 227.00(%)
  • Tata Chemicals
    688.00 581.30(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Jenburkt Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4394.0
  • ISIN : INE354A01013
979.90 -4 (-0.36%)
  • As on 19 Sep 2026 (EOD)

  • Today’s Low

    972.60

  • Today’s High

    997.00

  • Open

    985.00

  • Perv Close

    983.40

  • 52W Low

    960.30

  • 52W High

    1,073.90

Key Indicators

  • P/E(TTM)

    12.08

  • Mar.Cap (₹Cr.)

    432.46

  • Div & Yield %

    2.11

  • Book Value(₹)

    446.47

  • Debt-Equity Ratio

    -0.36

  • AGM Date

    18-Sep-2026

  • EPS

    80.96

  • P/E Ratio

    12.08

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    432.46

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    4.41

  • BV (₹)

    446.50

  • Sales( ₹ in Cr.)

    168.74

  • NP (in Cr.)

    37.34

  • NP Var(%)

    20.0

  • Div%

    207.0

  • CPS (₹)

    91.70

  • EPS (₹)

    84.60

  • Traded Value (₹ in Lakhs)

    431.62

  • 52 Week High

    1,073.90

  • 52 Week Low

    960.30

  • Price BSE

    978.0

  • Price NSE

    980.00

  • Market Capital( in Cr.)

    431.62

  • P/C Ratio

    10.70

  • P/E Ratio

    11.60

  • Price Vs.BV

    84.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 168.74 151.69 141.97 136.75 123.98 109.29
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 168.74 151.69 141.97 136.75 123.98 109.29
Other Income 10.30 6.72 4.67 5.12 4.95 4.31
Stock Adjustments 4.85 0.12 0.39 -1.34 2.28 -3.18
Total Income 183.89 158.53 147.03 140.53 131.21 110.42
EXPENDITURE :            
Raw Materials 37.17 29.77 30.80 31.67 33.72 26.91
Power and Fuel Cost 0.76 0.71 0.75 0.76 0.61 0.50
Employee Cost 49.88 45.54 42.49 38.81 36.49 32.38
Other Manufacturing Expenses 4.95 4.30 3.58 4.28 3.85 2.50
Selling and Administration Expenses 36.44 30.27 31.04 29.03 24.32 23.03
Miscellaneous Expenses 4.60 0.83 0.58 0.50 0.01 0.95
Employee Benefit Expenses 49.88 45.54 42.49 38.81 36.49 32.38
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 133.80 111.41 109.24 105.05 99.01 86.26
Operating Profit 50.09 47.11 37.79 35.49 32.20 24.15
Interest 0.46 0.45 0.27 0.37 0.43 0.47
Gross Profit 49.63 46.66 37.52 35.12 31.77 23.68
Depreciation 3.11 2.73 2.34 2.26 1.90 2.04
Profit Before Tax 46.52 43.93 35.18 32.86 29.87 21.64
Current Tax 12.64 12.08 9.72 8.48 7.28 5.53
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.86 -0.21 -0.52 -0.23 0.30 -0.39
Reported Net Profit 34.74 32.06 25.98 24.61 22.30 16.50
Extraordinary Items -2.61 1.02 0.04 0.00 0.14 0.00
Adjusted Net Profit 37.35 31.04 25.94 24.61 22.16 16.50
Adjustment below Net Profit 0.00 0.00 0.00 -14.34 0.00 0.00
P & L Balance brought forward 162.34 134.12 113.11 108.53 90.91 74.41
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 6.91 3.84 4.96 5.69 4.68 0.00
P & L Balance carried down 190.17 162.34 134.12 113.10 108.53 90.91
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 207.00 180.00 153.00 144.00 120.00 102.00
Dividend Per Share(Rs) 20.70 18.00 15.30 14.40 12.00 10.20
Earnings Per Share-Unit Curr 78.71 72.65 58.86 55.76 48.58 35.96
Earnings Per Share(Adj)-Unit Curr 78.71 72.65 58.86 55.76 48.58 35.96
Book Value 446.47 389.23 328.42 277.32 255.77 214.55
Book Value(Adj)-Unit Curr 446.47 389.23 328.42 277.32 255.77 214.55

Shareholding Pattern

  • Promoter Group

    46.62%

  • Public Share Holding

    53.38%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 616,128 13.96 616,128 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,441,322 32.66 1,441,322 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,057,450 46.62 2,057,450 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 5,355 0.12 5,355 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 5,355 0.12 5,355 2
2] Non Institution
Bodies Corporate 148,994 3.38 148,394 57
Clearing Members 3,956 0.09 3,956 6
Directors of their Relatives 900 0.02 900 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 136,268 3.09 136,268 180
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 54,152 1.23 54,152 193
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 454,445 10.30 454,445 9
Individuals holding nominal share capital up to Rs. 1 lakh 1,357,401 30.76 1,275,601 6,640
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 90,450 2.05 90,450 2
Others 103,929 2.35 103,929 2
Sub Total 2,350,495 53.26 2,268,095 7,091
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 4,413,300 100.00 4,330,900 7,103

Company Background

Jenburkt Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Jenburkt Pharmaceuticals Ltd
  • BSE Code : 4394.0
  • ISIN : INE354A01013

  • Incorporation Year

    1985

  • Registered Office

    Nirmala Apartment P B No 37396
    93 Jayprakash Road Andheri(W), Mumbai,
    Maharashtra-400058

  • Telephone

    91-22-66943121/67603603

  • FAX

    91-22-66943127

  • Chairman

    Ashish U Bhuta

  • Managing Director

  • Company Secretary

    ASHISH R SHAH

  • Auditor

    D R Mehta & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Jenburkt Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Jenburkt Pharma 978.00 179.04 168.74 13.15 24.65
Abbott India 27,273.30 7,217.19 6,929.05 35.89 43.78
Astrazeneca Phar 6,751.40 2,304.07 2,275.58 99.50 27.86
Glaxosmi. Pharma 2,851.85 3,932.76 3,790.20 45.56 58.17
Novartis India 2,057.50 393.10 354.33 51.96 15.94
Cipla 1,371.45 20,102.60 18,979.95 36.04 13.88
Bliss GVS Pharma 680.40 773.53 729.81 63.23 12.51
Amrutanjan Healt 493.65 520.13 502.55 26.44 24.16
Fermenta Biotec. 475.75 474.15 450.25 22.21 18.77
Guj. Themis Bio. 427.65 168.25 165.82 114.34 18.05
Ambalal Sarabhai 40.45 19.52 3.94 74.91 6.77